Cat. No. |
Product Name |
Information |
PC-35240 |
GSK180
KMO inhibitor
|
GSK180 (GSK-180) is a potent and specific inhibitor of kynurenine-3-monooxygenase (KMO) with IC50 of 6 nM, shows negligible activity against other enzymes on the tryptophan pathway. |
PC-42997 |
Ro 61-8048
KMO inhibitor
|
Ro 61-8048 is a potent, orally active Kynurenine 3-monooxygenase (KMO) inhibitor with IC50 of 37 nM. |
PC-62659 |
JM6
KMO inhibitor
|
JM6 (KMO inhibitor JM6) is an orally bioavailable small-molecule prodrug of Ro 61-8048, which is an inhibitor of kynurenine 3-monooxygenase (KMO). |
PC-61184 |
GSK366
KMO inhibitor
|
GSK366 is a novel potent kynurenine-3-monooxygenase (KMO) inhibitor with IC50 of 2.3 nM and 0.7 nM for human KMO and Pf-KMO, respectively. |
PC-61183 |
GSK065
KMO inhibitor
|
GSK065 is a novel potent kynurenine-3-monooxygenase (KMO) inhibitor with IC50 of 4.5 nM. |
PC-24007 |
UPF 648
KMO inhibitor
|
UPF 648 (UPF-648) is a potent, selective kynurenine 3-hydroxylase (KMO) inhibitor, increases the kynurenine and kynurenic acid concentration in vitro and in vivo. |